牡丹颗粒治疗糖尿病视网膜病变:缓解FBN2缺乏所致纤维化及TNF-α升高相关炎症
本研究在链脲佐菌素诱导的糖尿病小鼠模型中评价牡丹颗粒对糖尿病视网膜病变的保护作用,采用视网膜电图、组织病理学和血清生化指标评估疗效,并用蛋白质组学、UPLC-Q-TOF-MS和分子对接探索机制。结果显示牡丹颗粒显著保护视网膜功能、减轻视网膜厚度下降,调控70个与糖尿病视网膜损伤相关的生物标志物,并抑制TNF介导的炎症及视网膜新生血管和纤维化。
要点
- 牡丹颗粒可保护糖尿病小鼠视网膜功能并减轻视网膜厚度下降。
- 牡丹颗粒调控70个糖尿病视网膜损伤相关生物标志物,富集于TNF信号通路。
- 牡丹颗粒抑制TNF介导炎症,预防视网膜新生血管和纤维化。
核心结论
- 牡丹颗粒可能通过抑制纤维化相关新生血管和减轻炎症反应来缓解糖尿病视网膜功能障碍,恢复视网膜健康与功能。
研究设计与样本
- 研究建立糖尿病小鼠模型,连续5天腹腔注射60 mg/kg链脲佐菌素(STZ)。
主要发现
- 牡丹颗粒显著保护视网膜功能并有效减轻动物模型中观察到的视网膜厚度下降。
- 蛋白质组学分析显示牡丹颗粒调控70个与糖尿病视网膜损伤相关的生物标志物,这些蛋白显著富集于肿瘤坏死因子(TNF)信号通路。
- 糖尿病视网膜中纤维蛋白-2(FBN2)较对照组显著下调(0.36倍),在牡丹颗粒治疗组中上调最明显(3.26倍)。
- 分子对接分析显示牡丹颗粒成分与TNF-α之间存在强相互作用。
- 分子生物学方法证实牡丹颗粒可抑制TNF介导的炎症并预防视网膜新生血管和纤维化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Mudan granules (MuD), a time-honored traditional Chinese patent medicine (TCPM), are widely utilized in the clinical treatment of diabetic peripheral neuropathy (DPN). In the field of biomedical diagnostics, both diabetic retinopathy (DR) and DPN are recognized as critical microvascular complications associated with diabetes. According to the principles of traditional Chinese medicine (TCM), these conditions are primarily attributed to a deficiency in Qi and the obstruction of collaterals. Despite this, the protective effects of MuD on DR and the underlying mechanisms remain to be comprehensively elucidated. AIMS OF THE STUDY: The purpose of this study was to investigate the effect of MuD on DR and to further explore the promising therapeutic targets. METHODS: A diabetic mouse model was established by administering 60 mg/kg of streptozotocin (STZ) via intraperitoneal injection for five consecutive days. The therapeutic efficacy of MuD was evaluated using a comprehensive approach, which included electroretinogram (ERG) analysis, histopathological examination, and assessment of serum biochemical markers. Then, the pharmacodynamic mechanisms of MuD were systematically analyzed using Tandem Mass Tags-based proteomics. Meanwhile, the candidate compounds of MuD were analyzed by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC-Q-TOF-MS) and molecular docking was applied to estimate the affinity of the active ingredient to their potential key targets. In addition, the functional mechanisms identified through bioinformatics analysis were confirmed by molecular biological methods. RESULTS: We demonstrated that MuD provided significant protection to retinal function and effectively mitigated the reduction in retinal thickness observed in the animal model. Through proteomic analysis, we identified a substantial regulation by MuD of 70 biomarkers associated with diabetic retinal damage. These proteins were notably enriched in the tumor necrosis factor (TNF) signaling pathway, a critical mediator in inflammatory processes. A particularly intriguing finding was the significant downregulation of fibrillin-2 (FBN2) in the diabetic retina compared to the control group (0.36 times the level), and its most pronounced upregulation (3.26 times) in the MuD treatment group. This suggests that FBN2 may play a pivotal role in the protective effects of MuD. Molecular docking analyses have unveiled a robust interplay between the components of MuD and TNF-α. Further corroboration was provided by molecular biological methods, which confirmed that MuD could suppress TNF-mediated inflammation and prevent retinal neovascularization and fibrogenesis. CONCLUSION: MuD have the potential to alleviate diabetic retinal dysfunction by effectively curbing the fibrogenesis-associated neoangiogenesis and mitigating the inflammatory response, thereby restoring retinal health and function.
引用
- Long P, Guo C, Wen T, et al. Therapeutic effects of Mudan granules on diabetic retinopathy: Mitigating fibrogenesis caused by FBN2 deficiency and inflammation associated with TNF-α elevation. J Ethnopharmacol. 2024. PMID: 39490708. doi:10.1016/j.jep.2024.118963
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。